Dr. Reddy’s Laboratories trades high on the bourses

15 Nov 2016 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 3321.15, up by 60.50 points or 1.86% from its previous closing of Rs. 3260.65 on the BSE.

The scrip opened at Rs. 3265.00 and has touched a high and low of Rs. 3333.00 and Rs. 3265.00 respectively. So far 11167 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3689.00 on 20-Jul-2016 and a 52 week low of Rs. 2750.00 on 21-Jan-2016.

Last one week high and low of the scrip stood at Rs. 3333.00 and Rs. 2960.40 respectively. The current market cap of the company is Rs. 56600.48 crore.

The promoters holding in the company stood at 26.68%, while institutions and non-institutions held 43.64% and 12.69% respectively.

Dr. Reddy’s Laboratories has launched Raloxifene hydrochloride tablets in 60 mg, a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets in the United States market, approved by the U.S. Food & Drug Administration (USFDA). Dr. Reddys Raloxifene tablets are available in 60 mg in bottle count sizes of 30, 100 and 1,000.

The Evista brand and generic had U.S. sales of approximately $265 million MAT for the most recent twelve months ending in September 2016 according to IMS Health. Evista is a registered trademark of Eli Lilly and company.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1272.70 -2.35 (-0.18%)
08-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×